Symptomatic features and prognosis of 932 hospitalized patients with coronavirus disease 2019 in Wuhan

被引:11
|
作者
Sun, Liang Liang [1 ,2 ]
Wang, Jian [3 ]
Wang, Yu Sheng [4 ]
Hu, Ping Fang [3 ]
Zhao, Zheng Qing [2 ,5 ]
Chen, Wei [2 ,6 ]
Ning, Bei Fang [3 ]
Yin, Chuan [3 ]
Hao, Yu Shi [7 ]
Wang, Qiong [4 ]
Wang, Chen [4 ]
Liu, Ya Long [4 ]
Chen, Cheng [4 ]
Yin, Ji Zhong [4 ]
Huang, Hai [2 ,4 ]
Xie, Wei Fen [2 ,3 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
[2] Maternal & Child Hosp Hubei Prov, Opt Valley Branch, Wuhan, Hubei, Peoples R China
[3] Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, 415 Fengyang Rd, Shanghai 200003, Peoples R China
[4] Second Mil Med Univ, Changzheng Hosp, Dept Resp & Crit Care Med, 415 Fengyang Rd, Shanghai 200003, Peoples R China
[5] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai, Peoples R China
[6] Second Mil Med Univ, Changzheng Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China
[7] Second Mil Med Univ, Changzheng Hosp, Dept Med Psychol, Shanghai, Peoples R China
关键词
COVID-19; prognosis; SARS-CoV-2; symptomatic feature; COVID-19;
D O I
10.1111/1751-2980.12983
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective To discern the symptomatic features of coronavirus disease 2019 (COVID-19) and to evaluate the severity and prognosis of the disease. Methods In this retrospective cohort study, 932 hospitalized patients with COVID-19 in Wuhan were enrolled, including 52 severe and 880 non-severe cases. All patients were followed up for 3 months after discharge. The symptomatic features and follow-up data of the patients in both groups were analyzed and compared. Results Of the 932 patients, fever (60.0%), cough (50.8%) and fatigue (36.4%) were the most common symptoms. In total, 32.7% of the severe cases presented with gastrointestinal symptoms at disease onset, including anorexia, nausea, vomiting or diarrhea, which was significantly higher than that of the non-severe group (P = 0.0015). The incidence of olfactory disturbance and dysgeusia was only 3.1% and 6.2%, respectively. After adjusting for age and sex, multivariate regression analysis showed that fever lasting for over 5 days (odds ratio [OR] 1.90, 95% confidence interval [CI] 1.00-3.62, P = 0.0498), anorexia at onset (OR 2.61, 95% CI 1.26-5.40, P = 0.0096), and modified Medical Research Council level above grade 2 when dyspnea occurred (OR 14.19, 95% CI 7.01-28.71, P < 0.0001) were symptomatic risk factors for severe COVID-19. During the follow-up, cough (6.2%), dyspnea (7.2%), fatigue (1.8%), olfactory disturbance and dysgeusia (1.5%) were the significant remaining symptoms. Conclusions COVID-19 causes clusters of symptoms with multiple systems involved. Certain symptomatic characteristics have predictive value for severe COVID-19. Short-term follow-up data reveal that most patients have a good prognosis.
引用
收藏
页码:271 / 281
页数:11
相关论文
共 50 条
  • [41] A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
    Zhang Fengqin
    Wei Yanqiu
    He Li
    Zhang Huilan
    Hu Qiongjie
    Yue Huihui
    He Jianhan
    Dai Huaping
    中华医学杂志英文版, 2022, 135 (03) : 368 - 370
  • [42] Air Sampling for Fungus around Hospitalized Patients with Coronavirus Disease 2019
    Chen, Yi-Chun
    Lin, Yin-Shiou
    Kuo, Shu-Fang
    Lee, Chen-Hsiang
    JOURNAL OF FUNGI, 2022, 8 (07)
  • [43] Delirium and Associated Factors in a Cohort of Hospitalized Patients With Coronavirus Disease 2019
    Garcia-Grimshaw, Miguel
    Chiquete, Erwin
    Jimenez-Ruiz, Amado
    de Jesus Vidal-Mayo, Jose
    Lissete Grajeda-Gonzalez, Samara
    Angeles Vargas-Martinez, Maria de los
    Nicole Toapanta-Yanchapaxi, Liz
    Valdes-Ferrer, Sergio Ivan
    Alan Chavez-Martinez, Oswaldo
    Alexis Marche-Fernandez, Osvaldo
    Itiel Jimenez-Avila, Ana
    Cantu-Brito, Carlos
    Daniel Flores-Silva, Fernando
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 (01): : 3 - 13
  • [44] The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019
    Cap, Murat
    Bilge, Onder
    Isik, Ferhat
    Burak, Cengiz
    Karagoz, Ali
    Inci, Umit
    Akyuz, Abdurrahman
    Aslan, Burhan
    Altintas, Bernas
    Altindag, Rojhat
    Kaya, Ilyas
    Adiyaman, Mehmet Sahin
    Suleymanoglu, Muhammed
    Kaya, Safak
    Baysal, Erkan
    JOURNAL OF ELECTROCARDIOLOGY, 2020, 63 : 115 - 119
  • [45] Arrhythmias and Intraventricular Conduction Disturbances in Patients Hospitalized With Coronavirus Disease 2019
    Patel, Nishi H.
    Rutland, Josh
    Tecson, Kristen M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 162 : 111 - 115
  • [46] Asymptomatic coronavirus disease 2019 (COVID-19) in hospitalized patients
    Passarelli, Victor C.
    Faico-Filho, Klinger
    Moreira, Luiz V. L.
    Luna, Luciano Kleber de Souza
    Conte, Danielle D.
    Camargo, Clarice
    Perosa, Ana H.
    Bellei, Nancy
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (09): : 1158 - 1160
  • [47] Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury
    Briscoe, Michael
    Sykes, Robert
    Krystofiak, Thomas
    Peck, Oliver
    Mangion, Kenneth
    Berry, Colin
    CLINICAL CARDIOLOGY, 2021, 44 (03) : 332 - 339
  • [48] Clinical Significance of Coronavirus Disease 2019 in Hospitalized Patients With Myocardial Injury
    Briscoe, Michael
    Sykes, Robert A.
    Krysztofiak, Thomas
    Peck, Oliver H.
    Mangion, Kenneth
    Berry, Colin
    CIRCULATION, 2020, 142
  • [49] Risk Factors for Mortality in Hospitalized Coronavirus Disease 2019 Patients Response
    Chen, Ruchong
    Zhan, Chen
    Liang, Wenhua
    Zhong, Nanshan
    Li, Shiyue
    CHEST, 2020, 158 (06) : 2700 - 2701
  • [50] Comparison Between Hospitalized Patients Affected or Not Affected by Coronavirus Disease 2019
    Russo, Alessandro
    Bellelli, Valeria
    Ceccarelli, Giancarlo
    Cattaneo, Federica Marincola
    Bianchi, Luigi
    Pierro, Roberto
    Russo, Roberta
    Steffanina, Alessia
    Pugliese, Francesco
    Mastroianni, Claudio Maria
    d'Ettorre, Gabriella
    Sabetta, Francesco
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E1158 - E1159